Clinical trial
An Open-Label Study of the Pharmacokinetics of a Single Dose of Telavancin in Pediatric Subjects Aged 12 Months to 17 Years
NCT02013141 is registered in ClinicalTrials.gov with Cumberland Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Study of the Pharmacokinetics of a Single Dose of Telavancin in Pediatric Subjects Aged 12 Months to 17 Years
- Lead sponsor
- Cumberland Pharmaceuticals
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- December 31, 2014
- Completion date
- March 31, 2021
- Enrollment
- 22 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.